These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6689508)

  • 21. [Radiotelemetric study of the effects of antacids and cimetidine on intragastric pH (author's transl)].
    Isal JP; Caulin C; Lamotte M
    Nouv Presse Med; 1981 Jun; 10(28):2343-7. PubMed ID: 7267339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of acid consuming capacity of artificial gastric juice for antacid tablets.
    Jovanović M; Samardzić Z; Djurić Z; Zajić L
    Pharmazie; 1988 Mar; 43(3):214-5. PubMed ID: 3380869
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro study of the antipeptic activity of antacid preparations].
    Pawlaczyk J; Kokot Z; Rafińska A
    Acta Pol Pharm; 1985; 42(2):153-8. PubMed ID: 3936340
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro evaluation of liquid antacid products.
    Sherrill MC; Rudd GD
    Am J Hosp Pharm; 1982 Feb; 39(2):300-2. PubMed ID: 7058802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of neutralization capacity of antacids in gastric juice].
    Halter F
    Z Gastroenterol; 1983 Mar; 21 Suppl():33-40. PubMed ID: 6858409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Principles for development of antacids.
    Pilbrant A
    Scand J Gastroenterol Suppl; 1982; 75():32-6. PubMed ID: 6959248
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro antidiabetics-antacid interactions.
    Naggar VF; Khalil SA
    Pharmazie; 1980; 35(7):412-6. PubMed ID: 7413713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro interaction of a novel immunosuppressant, FK 506, and antacids.
    Steeves M; Abdallah HY; Venkataramanan R; Burckart GJ; Ptachcinski RJ; Abu-Elmagd K; Jain AK; Fung F; Todo S; Starzl TE
    J Pharm Pharmacol; 1991 Aug; 43(8):574-7. PubMed ID: 1717676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Testing the acid-binding capacity of Tisacid suspension and tablets by intragastric pH determination in patients with hyperacidity].
    Hunyady B; Ciráki A; Vińcze A; Garamszegi M; Nagy L; Jávor T
    Orv Hetil; 1994 Jun; 135(25):1353-6. PubMed ID: 8008366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the acid buffering capacity of dietary components regarding food-drug interactions].
    al-Behaisi S; Antal I; Morovján G; Drabant S; Plachy J; Marton S; Klebovich I
    Acta Pharm Hung; 2002; 72(3):185-90. PubMed ID: 12494789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neutralizing capacity and sodium content of antacid brands on the Kenyan market.
    Kibwage IO; Machine A; Hagos B; Hoogmartens J
    East Afr Med J; 1995 Mar; 72(3):194-7. PubMed ID: 7796775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic effects of antacids and interactions with other drugs].
    Gugler R; Musch E
    Z Gastroenterol; 1983 Mar; 21 Suppl():127-33. PubMed ID: 6858404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative evaluation of liquid antacids commercially available in the United Kingdom.
    Duffy TD; Fawzy SZ; Ireland DS; Rubinstein MH
    J Clin Hosp Pharm; 1982 Mar; 7(1):53-8. PubMed ID: 7096579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antacid on gastric and duodenal bulb acidity.
    Hannibal S; Remvig L; Rune SJ
    Scand J Gastroenterol Suppl; 1980; 58():29-36. PubMed ID: 6929092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New aspects of clinical pharmacology of antacids.
    Konturek SJ
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):5-21. PubMed ID: 8260735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desorption of atropine sulphate and hyoscyamine hydrobromide by various antacids in vitro.
    Singh A; Mital HC
    Pharmazie; 1982 Jan; 37(1):31-2. PubMed ID: 7071110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified and quantitative saliva buffer capacity test using a hand-held pH meter.
    Kitasako Y; Moritsuka M; Foxton RM; Ikeda M; Tagami J; Nomura S
    Am J Dent; 2005 Jun; 18(3):147-50. PubMed ID: 16158802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of antacids "in vitro"].
    Alvarez de Saldaña S; de Ramírez AF; Ramírez Mata M
    Rev Gastroenterol Mex; 1978; 43(3):127-30. PubMed ID: 33434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evaluation of antacids.
    Engel GB
    N Z Med J; 1969 Feb; 69(441):80-2. PubMed ID: 5252206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.